Teva Pharmaceuticals Settles Opioid-related Claims By West Virginia

Teva Pharmaceuticals and its affiliates has reached an agreement with the Attorney
General of West Virginia that settles the state's and its subdivisions opioid-related claims. Teva will provide the generic version of Narcan, valued at $27 million, over 10 years. The settlement will provide West Virginia with $75 million over 15 years in addition to $8 million in attorneys' fees and costs.

Teva Pharmaceuticals stated the settlement is another critical step forward in getting life-saving treatments to people suffering from addiction to opioids. Teva noted that the company continues to actively negotiate a national settlement.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. may face production shortfall of as many as 6 million iPhone Pro units this year due to ongoing protests at its major China plant, Bloomberg reported citing a person familiar with assembly operations. Following the news, Apple shares were losing around 2.2 percent in pre-market activity on the Nasdaq. Despite fears of inflation, consumers spent $9.12 billion for online shopping during Black Friday, higher than in previous years, as per a report published by Adobe Analytics. During the 2022 holiday season, total estimated revenues are $209.7 billion, a growth of 2.5 percent from last year's recorded revenues of $205 billion. Weis Markets, Inc., a Mid Atlantic food retailer, has recalled 108 containers of Weis Quality Sea Salt Caramel Ripple Ice Cream citing possible presence of undeclared soy and coconut allergens, the U.S. Food and Drug Administration said. The recalled product comes in 48oz containers that says Weis Quality Sea Salt Caramel Ripple Ice Cream, while the lid says Weis Quality Caramel Caribou Ice Cream
Follow RTT